
Interventional Cardiology Fellow @Texas_Heart via IM @UMiamiMedicine I Postdoctoral Research Fellowship @NorthwesternMed
Joined May 2020
- Tweets78
- Following530
- Followers241
- Likes425
Diego Celli, MD retweeted
We’ve spent a lot of time updating this to work with all medical specialties.
Please retweet and share.
Completely free to use. Just create an account here: chat.recodemedical.com
Lots of exciting updates to come!
Diego Celli, MD retweeted
@Texas_Heart & @BiVACOR are thrilled to announce the successful completion of the first-in-human implantation of the BiVACOR Total Artificial Heart as part of the U.S. FDA Early Feasibility Study: texasheart.org/the-texas-hea…
#HeartFailure #HeartDisease #Cardiology #MedTech
Diego Celli, MD retweeted
🧵 @InariMedical FLAME trial (largest ever high risk PE study) presented today @ACCinTouch #ACC23 by Mitch Silver!
Details in this thread below
Diego Celli, MD retweeted
Replying to @CardioNerds
@CardioNerds #CNCR recording in progress!!
Learning a ton from @Texas_Heart fellows @IsabelBalachan1 @celli_md and @AmitGoyalMD
Hint: Prep for this episode by reviewing these 2 phenomenal tweetorials by @AkivaRosenzveig
1⃣teapawt.net/AkivaRosenzveig/status…
2⃣teapawt.net/AkivaRosenzveig/status…
1/ We clinched the Dx, but how do we treat it?
Are these clot 📸 the best approach for #PE Rx?
Let’s dive into the 🌎 of "escalation of care" therapies
@CardioNerds 🧵 part 2...
Hold on to your 🎩 for this one
@PERTConsortium #PERT #CardioTwitter #ACCMedStudent
Diego Celli, MD retweeted
Top 10 #POCUS Papers of 2021
These aren't necessarily the best papers from last year, but they were papers that caught our interest
#VanPOCUS22 @VancouverPOCUS
Diego Celli, MD retweeted
FDA approved Mavacamten for #HOCM treatment. A cardiac myosin inhibitor that specifically targets the source of obstructive HCM. The EXPLORER-HCM trial demonstrated benefit versus placebo. EF must be >55%. Problem is pricing: $89,500/year #cardioED #cardiotwitter #echofirst
Diego Celli, MD retweeted
Superficial temporal artery access for PCI! Whaaaat.
#CardioTwitter
Not #radialfirst in this case!
ncbi.nlm.nih.gov/pmc/article…
Diego Celli, MD retweeted
Diego Celli, MD retweeted
Stetho = chest
Scope = see
Stethoscope can only hear and can't 'see', it's a stethophone!
#POCUS is the 'true' Stethoscope!
Diego Celli, MD retweeted
For any future #EPeeps consults for xenotransplantated hearts - here is a normal pig 12-lead ECG for reference!
Diego Celli, MD retweeted
🫀Pulmonary Arterial Hypertension 🫁
In this infographic for @CardioNerds Academy, we discuss diagnosis & management of PAH!
Thanks to
@GRamaniMD
@karanpdesai
@AmitGoyalMD
Diego Celli, MD retweeted
An updated list of Cardiology MedTweetorials
teapawt.net/i/events/1206752248749…
Diego Celli, MD retweeted
1/17
[Why] is furosemide susceptible to malabsorption from "gut edema"?
When a patient with heart failure is hospitalized with congestion I often hear "let's use IV furosemide; they're probably not absorbing the PO."
It's a comment unique to furosemide.
But is it accurate?
Diego Celli, MD retweeted
Texas Heart Institute is pleased to introduce our 2022-2023 Fellows!
•••
@celli_md @UMiamiMedicine @mghmedres @MassGeneralNews @RamseyKalilMD @nyphospital @weillcornell @umichmedicine @nyphospital @weillcornell @UTSWNews @UTSWInternalMed @MatthewRiesbeck @demanddeborah
Diego Celli, MD retweeted
It’s Match Day! The future of cardiovascular care is bright. Texas Heart Institute is proud to welcome the future leaders of cardiovascular care to our world-renowned training program.
Read more: https://teapawt.net/t.co/eaCSGVrVUf
#MatchDay2021 #THIFellowship #THIMatchDay #CardioTwitter
There are no words to describe how humbled and honored I feel to have matched at @Texas_Heart ; I am ecstatic to join the family.
An army of mentors guided me through this process, and I will be forever grateful to you. @russcolombomd @torresviera #EduardoDeMarchena
Diego Celli, MD retweeted
🌟#AVATAR Trial
In low-risk asymp pts w/ severe AS, early surgery⬇️primary endpoint (death, MI, stroke, or HF hosp), mainly driven by ⬇️death and HF hosp.
📍Intraop mortality in early surgery grp in line w/ anticipated mortality for elective SAVR.
#AHA21 @AHAScience @AHAMeetings










![Courtesy of @GoldbergJBCTMD [Dr. Joshua Goldberg]](https://pbs.twimg.com/media/Fp_aVGwX0AY9WNZ.jpg?name=small&format=webp)



















